New cough study demonstrates diphenhydramine to inhibit cough reflex with Dr. Cocoa form

October 11, 2014

SAN DIEGO, CA, October 11, 2014 - Cough is among the most common complaints for which patients seek medical attention. Leading cough researcher Peter V. Dicpinigaitis, M.D., Professor of Clinical Medicine at New York's Albert Einstein College of Medicine, recently conducted a new cough challenge study among adults, whose results were first presented at the European Respiratory Society International Congress in September 2014. The study was conducted using 22 adults with acute URI (common cold) who underwent cough reflex sensitivity measurement employing capsaicin challenge on 3 separate days, 2 hours after ingesting a single dose of study drug (to coincide with peak blood levels) that was administered in a randomized, double-blind manner: a multicomponent syrup containing diphenhydramine (25 mg), phenylephrine (10 mg), in a natural cocoa flavoring (Dr. Cocoa, Infirst Healthcare); dextromethorphan (30 mg) syrup; and, placebo syrup. The standard endpoint of cough challenge was used: the concentration of capsaicin inducing ≥5 coughs (C5).

The results showed that although both the diphenhydramine -containing and dextromethorphan formulations suppressed cough reflex sensitivity relative to placebo, only the degree of inhibition attained by the diphenhydramine-containing medication achieved statistical significance.

Over-the-counter cough medicines historically have been criticized for lack of scientific evidence supporting their efficacy. "This is the first study to demonstrate the ability of diphenhydramine to inhibit cough reflex sensitivity in subjects with acute viral respiratory tract infection (common cold)," explains Dr. Dicpinigaitis.

Dr. Dicpinigaitis will be providing these significant findings to show diphenhydramine's efficacy for cough symptom relief, using the new Dr. Cocoa™ formulation at the infirst Healthcare / Dr. Cocoa™ for Children exhibit booth (#1521) at this week's American Academy of Pediatrics Annual Meeting, October 11-14, in San Diego. Dr. Dicpinigaitis will be at the booth throughout the day on October 11 and 12 and will formally present the findings during these times:
-end-

New Dr. Cocoa™ for Children is the first-ever children's cough and cold medicine to combine trusted, effective ingredients like diphenhydramine with 10% real cocoa for a real chocolate taste to help make dosing easier. For more information, visit http://www.drcocoa.com.

About infirst Healthcare:

Dr. Cocoa™ for Children is owned and distributed by infirst Healthcare, Inc., a new consumer healthcare company founded in 2013. The company's mission is to apply advanced science to consumer medicines to create superior solutions to address un-met healthcare needs. The mission statement is "known drugs - made better." The Dr. Cocoa line of pediatric cough and cold medicines is infirst Healthcare's first technology launch in the U.S.

Robin Leedy & Associates, Inc.

Related Cocoa Articles from Brightsurf:

High social and ecological standards for chocolate
Worldwide demand for food from the tropics that meets higher environmental and social standards has risen sharply in recent years.

Hand pollination, not agrochemicals, increases cocoa yield and farmer income
Agroecologists from Göttingen University compare pesticides, fertilisers, manual pollination and farming costs in Indonesia

Growing demand for zero-deforestation cacao might not help Colombian forests
Cacao in Colombia is not a major driver of deforestation - yet.

Coffee, cocoa and vanilla: an opportunity for more trees in tropical agricultural landscapes
The cultivation of coffee, cocoa and vanilla secures the income of many small-holder farmers and also drives land-use change.

Cocoa could bring sweet relief to walking pain for people with peripheral artery disease
Patients with peripheral artery disease (PAD) who consumed a flavanol-rich cocoa beverage three times daily for six months saw significant improvements in their 6-minute walking distance compared to a placebo, in a small, phase II randomized study.

Researchers validate transferable & accessible method to quantify flavanols & procyanidins
Building on over two decades of research, Mars and the University of California Davis have developed a new methodology to measure cocoa flavanols and procyanidins that is more accurate and more reliable than previous analytical approaches.

How to fight illegal cocoa farms in Ivory Coast
The world's love for chocolate has helped decimate protected forests in western Africa as some residents have turned protected areas into illegal cocoa farms and hunting grounds.

The flavor of chocolate is developed during the processing of the cocoa beans
Can you manipulate the taste of noble cocoas in different directions to create exciting new flavours for the world's chocolate fans?

Fairtrade benefits rural workers in Africa, but not the poorest of the poor
A new study from the University of Göttingen and international partners has analysed the effects of Fairtrade certification on poor rural workers in Africa.

Why climate change means a rethink of coffee and cocoa production systems
New research by an international group of scientists, from Inland Norway University, Bioversity International, Wageningen University and World Agroforestry, examines whether incorporating suitable trees into crop systems or replacing coffee with cocoa could help the thousands of families in Mesoamerica meet future climate conditions.

Read More: Cocoa News and Cocoa Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.